APEX-STROKE CALM-ICH Domain
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1100 participants.
Also called NCT07752719
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,100 participants
- Sponsor
- Registry
-
NCT07752719
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07752719. Randomized; quadruple masking; primary purpose treatment. Start 2026-10-01 (anticipated); primary completion 2029-01-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- APEX-STROKE CALM-ICH Domain
- Acronym
- CALM-ICH
- Condition
- Stroke
- Condition
- Intracerebral Hemorrhage
- Intervention (Drug)
- Angong Niuhuang Pills (ANP)
- Intervention (Drug)
- Placebo
- Lead sponsor
- Fudan University
- Collaborator
- Huashan Hospital
- Collaborator
- Chinese PLA General Hospital
- Collaborator
- Beijing University of Chinese Medicine
- Collaborator
- Hubei College of Traditional Chinese Medicine
- Collaborator
- Guangdong Provincial Hospital of Traditional Chinese Medicine
Record details
- Record id
cardio:ct-nct07752719- Content hash
6e7262d65990d9d35a2dba1854358ca4897189ee5d9a5bce5f66433ae35e5363